The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Meritxell Arenas; Ugur Selek; Orit Kaidar-Person; Elisabetta Perrucci; Angel Montero Luis; Liesbeth Boersma; Charlotte Coles; Birgitte Offersen; Icro Meattini; Yasemin Bölükbaşı; Maria Cristina Leonardi; Raphael Pfeffer; Bruno Cutuli; Cristiana Vidali; Pierfrancesco Franco; Vassilis Kouloulias; Valeria Masiello; Sofia Rivera; Céline Bourgier; Antonella Ciabattoni; Valentina Lancellotta; Lurdes Trigo; Vincenzo Valentini; Philip Poortmans; Cynthia Aristei

doi:10.1016/j.critrevonc.2020.102967

The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Meritxell Arenas, Ugur Selek, Orit Kaidar-Person, Elisabetta Perrucci, Angel Montero Luis, Liesbeth Boersma, Charlotte Coles, Birgitte Offersen, Icro Meattini, Yasemin Bölükbaşı, Maria Cristina Leonardi, Raphael Pfeffer, Bruno Cutuli, Cristiana Vidali, Pierfrancesco Franco, Vassilis Kouloulias, Valeria Masiello, Sofia Rivera, Céline Bourgier, Antonella CiabattoniValentina Lancellotta, Lurdes Trigo, Vincenzo Valentini, Philip Poortmans, Cynthia Aristei

Risultato della ricerca: Contributo su rivista › Articolo di review › peer review

Abstract

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

Lingua originale	Inglese
Numero di articolo	102967
Rivista	Critical Reviews in Oncology/Hematology
Volume	151
DOI	https://doi.org/10.1016/j.critrevonc.2020.102967
Stato di pubblicazione	Pubblicato - lug 2020
Pubblicato esternamente	Sì

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.critrevonc.2020.102967

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Arenas, M., Selek, U., Kaidar-Person, O., Perrucci, E., Montero Luis, A., Boersma, L., Coles, C., Offersen, B., Meattini, I., Bölükbaşı, Y., Leonardi, M. C., Pfeffer, R., Cutuli, B., Vidali, C., Franco, P., Kouloulias, V., Masiello, V., Rivera, S., Bourgier, C., ... Aristei, C. (2020). The 2018 assisi think tank meeting on breast cancer: International expert panel white paper. Critical Reviews in Oncology/Hematology, 151, Articolo 102967. https://doi.org/10.1016/j.critrevonc.2020.102967

@article{b15e3db8ae5f4b0688dbf068c5c3df4d,

title = "The 2018 assisi think tank meeting on breast cancer: International expert panel white paper",

abstract = "We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy \& Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.",

keywords = "Breast cancer, Breast reconstruction, De-escalating therapy, Ductal carcinoma in situ, Hypofractionation, Neoadjuvant chemotherapy, Partial breast irradiation, Post-mastectomy radiation therapy, Radiation therapy",

author = "Meritxell Arenas and Ugur Selek and Orit Kaidar-Person and Elisabetta Perrucci and \{Montero Luis\}, Angel and Liesbeth Boersma and Charlotte Coles and Birgitte Offersen and Icro Meattini and Yasemin B{\"o}l{\"u}kba{\c s}ı and Leonardi, \{Maria Cristina\} and Raphael Pfeffer and Bruno Cutuli and Cristiana Vidali and Pierfrancesco Franco and Vassilis Kouloulias and Valeria Masiello and Sofia Rivera and C{\'e}line Bourgier and Antonella Ciabattoni and Valentina Lancellotta and Lurdes Trigo and Vincenzo Valentini and Philip Poortmans and Cynthia Aristei",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",

year = "2020",

month = jul,

doi = "10.1016/j.critrevonc.2020.102967",

language = "English",

volume = "151",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

Arenas, M, Selek, U, Kaidar-Person, O, Perrucci, E, Montero Luis, A, Boersma, L, Coles, C, Offersen, B, Meattini, I, Bölükbaşı, Y, Leonardi, MC, Pfeffer, R, Cutuli, B, Vidali, C, Franco, P, Kouloulias, V, Masiello, V, Rivera, S, Bourgier, C, Ciabattoni, A, Lancellotta, V, Trigo, L, Valentini, V, Poortmans, P & Aristei, C 2020, 'The 2018 assisi think tank meeting on breast cancer: International expert panel white paper', Critical Reviews in Oncology/Hematology, vol. 151, 102967. https://doi.org/10.1016/j.critrevonc.2020.102967

TY - JOUR

T1 - The 2018 assisi think tank meeting on breast cancer

T2 - International expert panel white paper

AU - Arenas, Meritxell

AU - Selek, Ugur

AU - Kaidar-Person, Orit

AU - Perrucci, Elisabetta

AU - Montero Luis, Angel

AU - Boersma, Liesbeth

AU - Coles, Charlotte

AU - Offersen, Birgitte

AU - Meattini, Icro

AU - Bölükbaşı, Yasemin

AU - Leonardi, Maria Cristina

AU - Pfeffer, Raphael

AU - Cutuli, Bruno

AU - Vidali, Cristiana

AU - Franco, Pierfrancesco

AU - Kouloulias, Vassilis

AU - Masiello, Valeria

AU - Rivera, Sofia

AU - Bourgier, Céline

AU - Ciabattoni, Antonella

AU - Lancellotta, Valentina

AU - Trigo, Lurdes

AU - Valentini, Vincenzo

AU - Poortmans, Philip

AU - Aristei, Cynthia

PY - 2020/7

Y1 - 2020/7

N2 - We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

AB - We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

KW - Breast cancer

KW - Breast reconstruction

KW - De-escalating therapy

KW - Ductal carcinoma in situ

KW - Hypofractionation

KW - Neoadjuvant chemotherapy

KW - Partial breast irradiation

KW - Post-mastectomy radiation therapy

KW - Radiation therapy

UR - https://www.scopus.com/pages/publications/85085021790

U2 - 10.1016/j.critrevonc.2020.102967

DO - 10.1016/j.critrevonc.2020.102967

M3 - Review article

SN - 1040-8428

VL - 151

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

M1 - 102967

ER -

The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Abstract

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo